Linfu Li

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 11

Top Topics

Signaling Pathway

Long Non Coding Rna

Top Venues

Future medicinal chemistry

Drug design, development and therapy

Food & function

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Ouyang, Yaosheng Xiao, Qun Ren, Jishang Huang, Qingluo Zhou, Shanshan Zhang, Linfu Li, Weimei Shi, Zhixi Chen, Longhuo Wu
7-Ketocholesterol Induces Oxiapoptophagy and Inhibits Osteogenic Differentiation in MC3T3-E1 Cells. Cells 11 (18) (2022)
Yizhou Zheng, Yaosheng Xiao, Di Zhang, Shanshan Zhang, Jing Ouyang, Linfu Li, Weimei Shi, Rui Zhang, Hai Liu, Qi Jin, Zhixi Chen, Daohua Xu, Longhuo Wu
Correction: Zheng et al. Geniposide Ameliorated Dexamethasone-Induced Cholesterol Accumulation in Osteoblasts by Mediating the GLP-1R/ABCA1 Axis. Cells 2021, 10 , 3424. Cells 11 (23) (2022)
Yizhou Zheng, Yaosheng Xiao, Di Zhang, Shanshan Zhang, Jing Ouyang, Linfu Li, Weimei Shi, Rui Zhang, Hai Liu, Qi Jin, Zhixi Chen, Daohua Xu, Longhuo Wu
Correction: Zheng et al. Geniposide Ameliorated Dexamethasone-Induced Cholesterol Accumulation in Osteoblasts by Mediating the GLP-1R/ABCA1 Axis. Cells 2021, 10 , 3424. Cells 11 (23) (2022)
Yizhou Zheng, Yaosheng Xiao, Di Zhang, Shanshan Zhang, Jing Ouyang, Linfu Li, Weimei Shi, Rui Zhang, Hai Liu, Qi Jin, Zhixi Chen, Daohua Xu, Longhuo Wu
Correction: Zheng et al. Geniposide Ameliorated Dexamethasone-Induced Cholesterol Accumulation in Osteoblasts by Mediating the GLP-1R/ABCA1 Axis. Cells 2021, 10 , 3424. Cells 11 (23) (2022)
Yizhou Zheng, Yaosheng Xiao, Di Zhang, Shanshan Zhang, Jing Ouyang, Linfu Li, Weimei Shi, Rui Zhang, Hai Liu, Qi Jin, Zhixi Chen, Daohua Xu, Longhuo Wu
Correction: Zheng et al. Geniposide Ameliorated Dexamethasone-Induced Cholesterol Accumulation in Osteoblasts by Mediating the GLP-1R/ABCA1 Axis. Cells 2021, 10 , 3424. Cells 11 (23) (2022)
Fang Peng, Xianhua Huang, Weimei Shi, Yaosheng Xiao, Qi Jin, Linfu Li, Daohua Xu, Longhuo Wu
5,7,3',4'-tetramethoxyflavone ameliorates cholesterol dysregulation by mediating SIRT1/FOXO3a/ABCA1 signaling in osteoarthritis chondrocytes. Future medicinal chemistry 13 (24) (2021)
Yizhou Zheng, Rui Zhang, Weimei Shi, Linfu Li, Hai Liu, Zhixi Chen, Longhuo Wu
Metabolism and pharmacological activities of the natural health-benefiting compound diosmin. Food & function 11 (10) (2021)
Hao Huang, Yizhou Zheng, Linfu Li, Weimei Shi, Rui Zhang, Hai Liu, Zhixi Chen, Longhuo Wu
The roles of post-translational modifications and coactivators of STAT6 signaling in tumor growth and progression. Future medicinal chemistry 12 (21) (2020)
Xiaohua Guo, Zhaowen Liu, Yizhou Zheng, Yamei Li, Linfu Li, Hai Liu, Zhixi Chen, Longhuo Wu
Review on the Structures and Activities of Transthyretin Amyloidogenesis Inhibitors. Drug design, development and therapy 14 (2020)
Linfu Li, Renbing Shi, Weimei Shi, Rui Zhang, Longhuo Wu
Oxysophocarpine protects airway epithelial cells against inflammation and apoptosis by inhibiting miR-155 expression. Future medicinal chemistry 12 (16) (2020)
Xianhua Huang, Zhixi Chen, Weimei Shi, Rui Zhang, Linfu Li, Hai Liu, Longhuo Wu
TMF inhibits miR-29a/Wnt/β-catenin signaling through upregulating Foxo3a activity in osteoarthritis chondrocytes. Drug design, development and therapy 13 (2019)